SMMT

Conviction 14HealthcareScan · Mon, Aug 10, 2026

Bullish marubozu

SMMT$14.88+6.59%

ResistanceSupportVol 14Insider buy

Vol MA14 3.9M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Summit Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.smmttx.com ↗

Price14.88

Change+6.59%

Gap+1.50%

Rel volume0.74×

Avg volume3.66M

Avg $ vol50.37M

SMA 2013.86

SMA 5014.35

SMA 20016.83

Price vs 50+3.68%

Price vs 200-11.61%

MA stackmixed

50/200 cross—

Supertrenddown · 15.45

RSI (14)57

MACD hist0.15

MACD crossbull · 2d

Stoch %K / %D76 / 54

ADX (14)16

+DI / −DI26 / 21

RSI divergence—

MACD divergence—

ATR %+5.40%

ADR %5.83%

52w high28.66

52w low12.55

From 52w high-48.08%

Above 52w low+18.57%

New 52w highNo

SqueezeOff

Bollinger width23.34%

%B0.81

Donchian pos76.12%

Donchian high15.71

Donchian low12.25

AVWAP (52w high)17.56

vs AVWAP high-15.28%

AVWAP (52w low)13.33

vs AVWAP low+11.63%

OBV trendFlat

Chaikin MF (20)-0.13

Today vs 20d0.74×

Avg vol (14d)3.9M

Avg vol (20d)3.66M

Avg $ vol (20d)50.37M

Market cap11.87B

RS 3m (vs SPY)-24.30%

RS 6m (vs SPY)-13.32%

RS line new highNo

Trend template1/8

Technical rank39.2

1 week+14.07%

1 month-2.43%

3 months-17.70%

6 months-0.73%

1 year-46.99%

YTD-15.07%

P/E-11.00

P/B18.84

P/S—

P/FCF-36.68

EPS-1.44

Div yield—

ROE-171.37%

ROA-143.53%

Debt/Eq—

Current6.96

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-387.81%

Price target27.68

Target upside86.02%

Analyst ratingBuy

Institutional16.89%

Ent. value11.45B

Revenue0

Net income-215.7M

Gross profit—

Free cash flow-323.59M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out776.16M

Employees265

ListedThu, Mar 5, 2015

Free float134.57M

Float %17.3%

Short interest37.33M

Days to cover11.0d

Short volume48.0%

Squeeze score70 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.28 vs −$0.26

Last surprise-7.7% miss

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank39.2 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish marubozu

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SMMT

All disclosures →

No recent disclosed trades by Congress in SMMT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SMMT · 3 buys

Insider	Side	Shares	Value	Traded	Filed
DUGGAN ROBERT W Co-Chief Executive Officer · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-04
Soni Manmeet Singh COO and CFO · Common Stock · 2026-06-04	Buy	25K	$361K	2026-06-04	2026-06-04
Zanganeh Mahkam Co-Chief Executive Officer · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-04
Zanganeh Mahkam Co-Chief Executive Officer · Common Stock · 2026-06-04	Buy	100K	$1.5M	2026-06-04	2026-06-04
DUGGAN ROBERT W Co-Chief Executive Officer · Common Stock · 2026-06-04	Buy	100K	$1.5M	2026-06-04	2026-06-04

SEC filings

EDGAR filings in SMMT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.